Expertise in
1
conditions

Christopher S. King

Holistic Medicine
15 Center St # 1, 
Ardsley, NY 
Expertise in
1
conditions
15 Center St # 1, 
Ardsley, NY 

Overview

Christopher King is a Holistic Medicine provider practicing medicine in Ardsley, New York.

Mr. King is highly rated in 1 condition, according to our data. His clinical expertise encompasses Pulmonary Fibrosis, Venous Thromboembolism (VTE), Gallbladder Disease, Endoscopy, and Embolectomy.

He is actively involved in clinical research, co-authoring 143 peer reviewed articles and participating in 8 clinical trials.

Specialties

Holistic Medicine

Licenses

Acupuncturist in NY

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Cigna
  • EPO
  • HMO
  • PPO

Locations

15 Center St # 1, Ardsley, NY 10502
Other Locations
302-1 Fremont Street, Peekskill, NY 10566

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-1)
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-1)
Enrollment Status: Completed
Publish Date: May 05, 2026
Intervention Type: Device, Drug
Study Drug: Treprostinil
Study Phase: Phase 3
Extracorporeal Photopheresis for the Management of Progressive Bronchiolitis Obliterans Syndrome in Medicare-Eligible Recipients of Lung Allografts
Extracorporeal Photopheresis for the Management of Progressive Bronchiolitis Obliterans Syndrome in Medicare-Eligible Recipients of Lung Allografts
Enrollment Status: Active_not_recruiting
Publish Date: April 06, 2026
Intervention Type: Combination product, Other
Study Drug: Extracorporeal Photopheresis (ECP)
Study Phase: Phase 3
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Enrollment Status: Terminated
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: Inhaled treprostinil solution
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Dose Escalation and Verification Clinical Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide (iNO) in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis on Long Term Oxygen Therapy (Part 1 and Part 2) - REBUILD
A Randomized, Double-Blind, Placebo-Controlled Dose Escalation and Verification Clinical Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide (iNO) in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis on Long Term Oxygen Therapy (Part 1 and Part 2) - REBUILD
Enrollment Status: Terminated
Publish Date: July 27, 2023
Intervention Type: Combination product
Study Drug: INOpulse
Study Phase: Phase 3
Pulmonary Fibrosis Foundation Patient Registry
Pulmonary Fibrosis Foundation Patient Registry
Enrollment Status: Completed
Publish Date: July 07, 2023
A Prospective, Multi-Center, Randomized, Controlled, Pivotal Trial to Validate the Safety and Efficacy of the Hemolung® Respiratory Assist System for COPD Patients Experiencing an Acute Exacerbation Requiring Ventilatory Support
A Prospective, Multi-Center, Randomized, Controlled, Pivotal Trial to Validate the Safety and Efficacy of the Hemolung® Respiratory Assist System for COPD Patients Experiencing an Acute Exacerbation Requiring Ventilatory Support
Enrollment Status: Terminated
Publish Date: October 14, 2022
Intervention Type: Device
Study Phase: Not Applicable
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
Pulmonary Rehabilitation in COPD: Response to Inhaled Treprostinil (Tyvaso)
Pulmonary Rehabilitation in COPD: Response to Inhaled Treprostinil (Tyvaso)
Enrollment Status: Terminated
Publish Date: April 12, 2022
Intervention Type: Drug
Study Phase: Phase 2
View 7 Less Clinical Trials

143 Total Publications

Efficacy and safety of single antiplatelet therapy with anticoagulation in patients with AMI-cardiogenic shock requiring VA-ECMO.
Efficacy and safety of single antiplatelet therapy with anticoagulation in patients with AMI-cardiogenic shock requiring VA-ECMO.
Journal: Perfusion
Published: June 10, 2026
Similar Doctors
Expertise in
2
conditions
Michael H. Cho
Holistic Medicine
Expertise in
2
conditions
Michael H. Cho
Holistic Medicine
Referral may be required
242 N Main St, 
New City, NY 
 (12.8 miles away)
845-321-4725
Languages Spoken:
English

Michael Cho is a Holistic Medicine provider practicing medicine in New City, New York. Mr. Cho is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Emphysema and Pulmonary Fibrosis.

Expertise in
17
conditions
Min Z. Wang
Holistic Medicine
Expertise in
17
conditions
Min Z. Wang
Holistic Medicine
Referral may be required
475 White Plains Rd Ste 22, 
Eastchester, NY 
 (4.3 miles away)
845-490-4466
Languages Spoken:
English

Min Wang is a Holistic Medicine provider practicing medicine in Eastchester, New York. Ms. Wang is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Periodontitis, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), PIK3CA-Related Overgrowth Spectrum, Pancreaticoduodenectomy, and Endoscopy.

Expertise in
1
conditions
Henry Lee
Holistic Medicine
Expertise in
1
conditions
Henry Lee
Holistic Medicine
Referral may be required

E.W. Natural Healing Acupuncture P.C.

21 W Nicholai St, 
Hicksville, NY 
 (23.8 miles away)
516-822-6722
Languages Spoken:
English

Henry Lee is a Holistic Medicine provider practicing medicine in Hicksville, New York. Mr. Lee is highly rated in 1 condition, according to our data. His clinical expertise encompasses Succinic Semialdehyde Dehydrogenase Deficiency.

Frequently Asked Questions about Christopher S. King

How do I make an appointment with Christopher S. King?

You can book an appointment with Christopher S. King by calling their office at 914-488-5763. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Christopher S. King a top-rated expert for Pulmonary Fibrosis?

MediFind is an objective health platform that identifies experts based on real-world data. Christopher S. King is classified as an Elite expert for Pulmonary Fibrosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Christopher S. King specialize in?

While Christopher S. King is a Holistic Medicine, they have specific expertise in Pulmonary Fibrosis, Venous Thromboembolism (VTE), and Endoscopy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Holistic Medicine.

Does Christopher S. King participate in research or clinical trials?

Yes. Christopher S. King has published 143 articles and abstracts on conditions like Pulmonary Fibrosis. You can view a list of Christopher S. King's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Christopher S. King accept my insurance?

Christopher S. King accepts most major insurance plans, including Cigna. We recommend calling the office directly at 914-488-5763 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. King's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile